Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 408
Selected: 0
NCT IDTitle
NCT05293015NP-Supported Multidisciplinary Diabetes Management During Perioperative Period
NCT01944943Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic Leukemia
NCT01028092mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation
NCT00352092Pilot Study for HLA Identical Living Donor Renal Transplant Recipients
NCT01847677Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin
NCT01195298Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer
NCT00400738The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients
NCT04470947Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies
NCT00217152A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors
NCT04389541Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology
NCT01016639Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer
NCT00293072Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis
NCT00440167Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine
NCT03911219Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy
NCT05975242Acceptability & Impact of a Diabetes Management Smartphone App (mySugr) for Spanish-literate Adults With Type 2 Diabetes
NCT05300282Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients
NCT02562378T-DM1 and Non-pegylated Liposomal Doxorubicin in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer
NCT03224208Vemurafenib Plus Cobimetinib in Advanced or Metastatic Melanoma Patients
NCT00219739STI571 ProspectIve RandomIzed Trial: SPIRIT
NCT01752192Teledi@Log - Tele-rehabilitation of Heart Patients
NCT01828736Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma
NCT00208546Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer
NCT00411762A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma
NCT01185223Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation
NCT01208896Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Relapsed Follicular Lymphoma
NCT00544765Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary Breast Cancer
NCT02012634Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer
NCT00875979A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab
NCT01370772Intensified Rituimab Prephase Before FCR in Untreated B-CLL
NCT04808245A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas
NCT00170170Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation
NCT01205854Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial
NCT02049853The Triple A Initiative Study ("Aktionsbündnis Akute Atemnot")
NCT03474094Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy
NCT01953458Therapeutic Option for Hepatitis B and C: a French Cohort
NCT04759248Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer
NCT02666898Phase II Trial GA101 Inbrutinib B CLL
NCT00944684High Dose Ribavirin in the Treatment of Chronic Hepatitis C
NCT01062555Calcineurin Inhibitor Sparing After Kidney Transplantation
NCT01167049Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis
NCT00391638Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients
NCT00895206Individually Adapted Immunosuppression in de Novo Renal Transplantation Based on Immune Function Monitoring: a Prospective Randomised Study
NCT03915678Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors
NCT01523340A Prospective Observational Study Evaluating c-MET Expression and EGFR Gene Mutation Correlation With Erlotinib Response
NCT04611867Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)
NCT01450137Tocilizumab for Patients With Giant Cell Arteritis
NCT00476502Study of Genetic Polymorphisms in Thai HIV-1 Infected Patients on SQV/r
NCT02992704Peg-interferon for Inactive Chronic Hepatitis B Carriers
NCT00976456Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer
NCT00620269Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III